+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Morphabond ER 2018 U.S. Promotional Audit Report

  • ID: 4615941
  • Report
  • Region: United States
  • 26 pages
  • MD Details
1 of 3

FEATURED COMPANIES

The 5 Key Questions Addressed by this Report:
  • How many physicians were reached by Morphabond ER through reportable promotional activity in 2018 and how does this compare to its peer set in the Pain - Opioids market?
  • What promotional mix was leveraged (e.g., sales rep detailing, physician education, and paid speaking) and what was the median spend for each type of activity?
  • How does Daiichi Sankyo's depth of coverage vary within key specialties (e.g., Anesthesiology, Family Medicine, Physical Medicine and Rehabilitation, Pain Medicine, and Internal Medicine) and how does this compare to its peers and the overall set of rep-accessible physicians?
  • How often are physicians receiving paid meals for Morphabond ER throughout the year (e.g., monthly, quarterly, annually)?
  • Who were the most frequent meal recipients and top paid speakers for Morphabond ER in 2018?
Data Sources and Methodology:
  • Author leverages company-reported financial transaction data disclosed through CMS Open Payments. This data set captures all transfers of value (e.g., speaking fees, consulting fees, travel, education, and meals) made on behalf of a drug or device manufacturer to a physician. Currently, over 5 years of longitudinal data is available - covering payments to more than 1,000,000 U.S. healthcare professionals.
  • Over 30,300 paid interactions across 5,200 physicians made on behalf of Morphabond ER were carefully examined to support our analysis. In addition, interaction data from 11 peer products (i.e. Arymo ER, Belbuca, Embeda, Hysingla ER, Levorphanol, Nucynta, Oxaydo, OxyContin, Subsys, Xtampza ER, and Zohydro ER) was leveraged to provide benchmarking and market insights.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

Overview:
  • Introduction
  • Sunshine Act and Open Payments Data
  • Transfer of Value
  • Author's Platform
Morphabond ER - Peer Set:
  • Morphabond ER Peer Set Selection
Morphabond ER - Promotional Benchmarking:
  • Chart 1 Total Number of Physicians Reached by Specialty Type
  • Chart 2 Distribution of Physicians Reached by Specialty Type
  • Chart 3 Total Number of Payments by Type
  • Chart 4 Distribution of Payments by Type
  • Chart 5 Total Number of Payments / Week
  • Chart 6 Payment Value by Type
Morphabond ER - Physician Coverage by Geography:
  • Chart 7 Anesthesiology
  • Chart 8 Family Medicine
  • Chart 9 Physical Medicine and Rehabilitation
  • Chart 10 Pain Medicine
  • Chart 11 Internal Medicine
Morphabond ER - Meal Frequency:
  • Chart 12 Anesthesiology
  • Chart 13 Family Medicine
  • Chart 14 Physical Medicine and Rehabilitation
  • Chart 15 Pain Medicine
  • Chart 16 Internal Medicine
Morphabond ER - Most Engaged Physicians:
  • Table 1: Top Physicians (By Total Number of Meals) in 2018
  • Table 2: Top Speakers (By Total Number of Speaking Events) in 2018
About:
  • Background
  • Service Lines
  • Contact
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Daiichi Sankyo
Note: Product cover images may vary from those shown
Adroll
adroll